Malaria is caused by Plasmodium parasites, and infection with P. falciparum can advance quickly to severe or life-threatening illness [1]. The species is distinguished by its capacity for rapid deterioration and severe organ involvement compared with other forms of malaria [1][4].
Disease overview
Parasitic Evidence-backed information EN 5/7 applicable sections · ZH 5/7 applicable sections Updated Oct 23, 2026
Plasmodium falciparum malaria is a parasitic infection that can progress rapidly to severe or life-threatening disease and is especially common across sub-Saharan Africa [1]. Southeast Asia has served as a persistent source of drug-resistant strains, most recently with artemisinin resistance threatening control gains [2][3]. Vaccine research using whole sporozoite platforms has shown potential for sustained protective immunity in humans [4].
Read the full clinical and epidemiological profile 6
Affected individuals may experience fever, chills, headache, and gastrointestinal symptoms, with anemia and neurologic manifestations possible as the disease worsens [1]. The asexual blood-stage parasites release waste products such as hemozoin that stimulate cytokine production and produce fever and rigors [1]. Severe disease may include organ complications, and the incubation period after an infective mosquito bite typically ranges from 7 to 30 days, often shorter for P. falciparum [1][2].
P. falciparum is widespread in many endemic countries, with the greatest burden and severe-disease risk concentrated in sub-Saharan Africa [1][3]. Over five decades the parasite has sequentially developed resistance to all major antimalarial drug classes, with resistance spreading in prevalence and geographic range [3].
The principal route is the bite of infected female Anopheles mosquitoes, which introduces sporozoites that later develop in the blood stage [1][3]. Rare alternative routes include blood transfusion, organ transplantation, needle sharing, and congenital passage [1]. Drug-resistance determinants such as K13 mutations alter parasite biology but do not change the mosquito-borne transmission mechanism [5].
Avoiding mosquito bites and using indicated antimalarial prophylaxis are central travel-prevention measures, with prophylaxis effective when taken as prescribed [1]. Whole sporozoite vaccine approaches have demonstrated high-level protective immunity in humans and may substantially reduce morbidity if licensed [4]. In contexts of emerging or established drug resistance, vector control, early diagnosis, and new drug combinations are recommended to disrupt transmission [3][5].
- 1 US Centers for Disease Control and Prevention. Clinical Features of Malaria | Malaria | CDC [Internet]. cited 23 Oct 2026. Available from: https://www.cdc.gov/malaria/hcp/clinical-features/index.html
- 2 Fairhurst RM et al. Artemisinin-Resistant Plasmodium falciparum Malaria. Microbiol Spectr. 2016 Jun. PMID: 27337450. doi: 10.1128/microbiolspec.EI10-0013-2016. PubMed: https://pubmed.ncbi.nlm.nih.gov/27337450/
- 3 Thu AM et al. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 2017 Aug. PMID: 28580606. doi: 10.1111/febs.14127. PubMed: https://pubmed.ncbi.nlm.nih.gov/28580606/
- 4 Epstein JE et al. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review. Curr Opin Infect Dis. 2013 Oct. PMID: 23982233. doi: 10.1097/QCO.0000000000000002. PubMed: https://pubmed.ncbi.nlm.nih.gov/23982233/
- 5 Wicht KJ et al. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria. Annu Rev Microbiol. 2020 Sep 8. PMID: 32905757. doi: 10.1146/annurev-micro-020518-115546. PubMed: https://pubmed.ncbi.nlm.nih.gov/32905757/
- B50
- 1F40
Loading current data…
Country surveillance trends
Choose a country, source, and measure. Each line retains its published reporting period and definition.
Loading data…
Coverage
Reporting countries and regions
The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.
Loading current data…
Surveillance pattern
Year × month seasonality by country
Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.
Research Radar
Recent related research
Modeling the potential effect of cabamiquine-pyronaridine for chemoprevention against Plasmodium falciparum malaria
Antimicrobial Agents and Chemotherapy
Recurrent Plasmodium falciparum Malaria after Delayed Hemolysis Induced by Artemether–Lumefantrine
The American Journal of Tropical Medicine and Hygiene
Peer reviewed Open access Possible disease match Plasmodium falciparum malaria Transmission dynamics
DOI 10.3389/fcimb.2026.1978670 ↗ Clinical contribution of mNGS in the diagnosis and management of imported falciparum malaria in a malaria-free region: a five-case series from northern China
Frontiers in Cellular and Infection Microbiology
Retrospective study of association between Plasmodium falciparum malaria density and platelet count at Presbyterian Hospital, Agogo
Frontiers in Malaria
Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adults.
Malaria journal
Showing 5 of 35 related publications.
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Loading official alerts…
Downloads and methods
Choose a time range and download CSV, JSON or XLSX files.